Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer-Reference-Cited by-同舟云学术

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

Published:2016-09-15 Issue:3 Volume:24 Page:473-482
ISSN:1340-6868
Container-title:Breast Cancer
language:en
Short-container-title:Breast Cancer

Author:

Ogiya Akiko, ,Yamazaki Kieko,Horii Rie,Shien Tadahiko,Horimoto Yoshiya,Masuda Norikazu,Inao Touko,Hosoda Mitsuchika,Ishida Naoko,Osako Tomofumi,Takahashi Masato,Endo Yumi,Miyoshi Yuichiro,Yasojima Hiroyuki,Tomioka Nobumoto,Yamashita Hiroko

Funder

Japanese Breast Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12282-016-0730-3.pdf

Reference22 articles.

1. Jatoi I, Anderson WF, Jeong JH, Redmond CK. Breast cancer adjuvant therapy: time to consider its time-dependent effects. J Clin Oncol. 2011;29:2301–4.

2. Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738–46.

3. Goss PE, Ingle JN, Pater JL, Martino S, Robert NJ, Muss HB, et al. Late extended adjuvant treatment with letrozole improves outcome in women with early stage breast cancer who complete 5 years of tamoxifen. J Clin Oncol. 2008;26:1948–55.

4. Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, et al. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a. J Natl Cancer Inst. 2007;99:1845–53.

5. Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381:805–16.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomogram for predicting distant metastasis and prognosis in HR+/HER2- breast cancer patients without lymph node metastasis;2023-08-11

2. Evaluation of 95-Gene Classifier of Formalin-fixed Paraffin-embedded Tissues in ER-positive, HER2-negative, and Node-negative Breast Cancer;Anticancer Research;2023-01-25

3. Mortality After Late Breast Cancer Recurrence in Denmark;Journal of Clinical Oncology;2022-05-01

4. Late Recurrence Following Early Breast Cancer;Journal of Clinical Oncology;2022-05-01

5. Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study;Japanese Journal of Clinical Oncology;2022-03-16